D. De-la, Réponse (en%) de l'échantillon patients-parents sur l'origine hématologique, Graphique, vol.38, p.104

. La-fiche-réalisée, être un support simple de prévention des crises drépanocytaires, complication essentielle de cette pathologie

S. Du, Le Siklos®, malgré ses nombreux effets indésirables, est une avancée majeure dans la prévention des crises drépanocytaires

. Haute-autorité-de-la-santé, URL : http://www.has-sante, 2011.

J. Herrick, Peculiar elongated sickle-shaped red blood corpuscles in a case of severe anemia, Arch Internal Medicine (USA), vol.6, p.517, 1910.

V. Emmel, A STUDY OF THE ERYTHROCYTES IN A CASE OF SEVERE ANEMIA WITH ELONGATED AND SICKLE-SHAPED RED BLOOD CORPUSCLES, Archives of Internal Medicine, vol.XX, issue.4, p.586, 1917.
DOI : 10.1001/archinte.1917.00090040108005

H. Lehmann, Sickle-cell Trait in Southern India, BMJ, vol.1, issue.4755, pp.404-405, 1952.
DOI : 10.1136/bmj.1.4755.404

URL : http://europepmc.org/articles/pmc2022731?pdf=render

L. Pauling, H. Itano, S. Sj, and I. Wells, Sickle Cell Anemia, a Molecular Disease, Science, vol.110, issue.2865, p.543, 1949.
DOI : 10.1126/science.110.2865.543

J. Neel, The Inheritance of Sickle Cell Anemia, Science, vol.110, issue.2846, p.64, 1949.
DOI : 10.1126/science.110.2846.64

M. Gladwin, Current and Future Therapies of Sickle Cell Anemia: An Historical Perspective, Hematology, vol.2008, issue.1, 2008.
DOI : 10.1182/asheducation-2008.1.176

R. Hebbel, O. Yamada, C. Moldow, H. Jacob, J. White et al., Abnormal adherence of Sickle Erythrocytes to cultured vascular endothelium:possible mechanism for microvascular occlusion in sickle cell disease, J Clin Invest, vol.65, p.156, 1980.

N. Luzzattol, E. Reddy, and S. , Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. The Lancet, p.319, 1970.

L. Kéclard, R. M. Saint-martin, and C. , Epidémiologie des gènes globines dans le bassin caribéen in La drépanocytose, regards croisés sur une maladie orpheline (dir, Lainé A.),éditions Khartala, pp.75-94, 2004.

P. Basset, Y. Beuzard, M. C. Garel, and J. Rosa, The isoelectric focusing of human haemoglobins and its application to screening to the characterisation of seventy variants , and to the study of modified fractions of normal haemoglobins, Blood, vol.51, pp.971-982, 1978.

R. L. Nagel, M. E. Fabry, and M. H. Steinberg, The paradox of hemoglobin SC disease Blood rev, pp.167-178, 2003.

O. S. Platt, D. J. Brambilla, W. F. Rosse, P. F. Milner, O. Castro et al., Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death, New England Journal of Medicine, vol.330, issue.23
DOI : 10.1056/NEJM199406093302303

J. M. Gonzalez-redondo, T. A. Stoming, K. D. Lanclos, Y. C. Gu, A. Kutlar et al., Clinical and genetic heterogeneity in black patients with homozygous betathalassemia from the southeastern United States, Blood, vol.72, pp.1007-1014, 1988.

D. Labie and J. Elion, Géneétique et physiopathologie de la drépanocytose, John Libbey, pp.1-11, 2003.

W. A. Eaton and J. Hofrichter, Hemoglobin S gelation and sickle cell disease, Blood, vol.70, pp.1245-1266, 1987.

J. P. Cartron and J. Elion, Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea, Transfusion Clinique et Biologique, vol.15, issue.1-2, pp.39-50, 2008.
DOI : 10.1016/j.tracli.2008.05.001

K. Kiryluk, A. Jadoon, M. Gupta, and J. Radhakrish, Sickle cell trait and gross hematuria, Kidney International, vol.71, issue.7, pp.706-710, 2007.
DOI : 10.1038/sj.ki.5002060

URL : https://doi.org/10.1038/sj.ki.5002060

E. Jacob, J. E. Beyer, C. Miaskowski, M. Savedra, M. Treadwell et al., Are There Phases to the Vaso-Occlusive Painful Episode in Sickle Cell Disease?, Journal of Pain and Symptom Management, vol.29, issue.4, pp.392-400, 2005.
DOI : 10.1016/j.jpainsymman.2004.07.006

K. A. Anie, Psychological complications in sickle cell disease, British Journal of Haematology, vol.148, issue.6, pp.723-729, 2005.
DOI : 10.1001/archpedi.1994.02170050015003

U. Omanga, N. Muganga, and M. Kapepela, Septicemies bacteriennes de l'enfant drepanocytairehomozygote, Ann Pediatr, vol.5, pp.315-318, 1989.

K. Ohene-frempong, S. J. Weiner, L. A. Sleeper, S. T. Miller, S. Embury et al., Cerebrovascularaccidents in sickle cell disease: rates and risk factors, Blood, vol.91, pp.288-294, 1998.

S. M. Rothman, K. H. Fulling, and J. S. Nelson, Sickle cell anemia and central nervous system infarction: A neuropathological study, Annals of Neurology, vol.12, issue.6, pp.684-690, 1986.
DOI : 10.1001/archpedi.1923.04120140031004

J. A. Switzer, D. C. Hess, F. T. Nichols, and R. J. Adams, Pathophysiology and treatment of stroke in sickle-cell disease: present and future, The Lancet Neurology, vol.5, issue.6, pp.501-512, 2006.
DOI : 10.1016/S1474-4422(06)70469-0

D. Montalembert, M. Beauvais, P. Bachir, D. Galacteros, F. Girot et al., Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease Eur, J.Pediatr, vol.152, pp.201-204, 1993.

F. J. Kirkham, Therapy Insight: stroke risk and its management in patients with sickle cell disease, Nature Clinical Practice Neurology, vol.103, issue.5, pp.264-278, 2007.
DOI : 10.1001/archotol.1977.00780230091016

S. K. Ballas and M. J. Marcolina, Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia, Transfusion, vol.8, issue.1, pp.105-110, 2006.
DOI : 10.1016/S0002-8703(97)70091-7

A. M. Emond, R. Holman, R. J. Hayes, and G. R. Serjeant, Priapism and impotence in homozygous sickle cell diseaseArch, Intern. Med, vol.140, pp.1434-1437, 1980.
DOI : 10.1001/archinte.140.11.1434

J. J. Fowler, M. Koshy, M. Strub, and S. K. Chin, Priapism Associated With the Sickle Cell Hemoglobinopathies: Prevalence, Natural History and Sequelae, The Journal of Urology, vol.145, issue.1, pp.65-68, 1991.
DOI : 10.1016/S0022-5347(17)38248-4

A. Stuart, S. M. Jones, and L. J. Walker, Insights into elevated distortion product otoacoustic emissions in sickle cell disease: Comparisons of hydroxyurea-treated and non-treated young children, Hearing Research, vol.212, issue.1-2, pp.83-89, 2006.
DOI : 10.1016/j.heares.2005.10.014

A. Guasch, J. Navarrete, K. Nass, and C. F. Zayas, Glomerular Involvement in Adults with Sickle Cell Hemoglobinopathies: Prevalence and Clinical Correlates of Progressive Renal Failure, Journal of the American Society of Nephrology, vol.17, issue.8, pp.2228-2235, 2006.
DOI : 10.1681/ASN.2002010084

M. T. Gladwin, V. Sachdev, M. L. Jison, Y. Shizukuda, J. F. Plehn et al., Pulmonary hypertension as a riskfactor for death in patients with sickle cell disease N

J. L. Gerry, B. H. Bulkley, and G. M. Hutchins, Clinicopathologic analysis of cardiac dysfunction in 52 patients with sickle cell anemia, The American Journal of Cardiology, vol.42, issue.2, pp.211-216, 1978.
DOI : 10.1016/0002-9149(78)90902-5

P. Basset, Y. Beuzard, M. Garrel, and R. J. , Isoelectric focusing of human hemoglobin: its application to screening, to the characterization of 70 variants, and to the study of modified fraction of normal hemoglobins, Blood, vol.51, pp.971-82, 1978.

A. Recommandations, Transfusion de globules rouges homologues : produits, indications, alternatives, 2002.

S. Charache, Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia, New England Journal of Medicine, vol.332, issue.20, pp.1317-1339, 1995.
DOI : 10.1056/NEJM199505183322001

S. Orah and M. D. Platt, Hydroxyurea for the Treatment of Sickle Cell Anemia, N Engl J Med, vol.358, pp.1362-1371, 2008.